Over the past 3 months, 13 analysts have published their opinion on Teladoc Health (NYSE:TDOC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Latest Ratings for TDOC
DateFirmActionFromTo Mar 2022Piper SandlerMaintainsOverweight Mar 2022UBSMaintainsNeutral Mar 2022Argus ResearchUpgradesHoldBuy
View More Analyst Ratings for TDOC
View the Latest...